Independent and not affiliated with the FDA, MHRA, ISPE, PDA, or any agency. Get the appgoutham@madhadi.com
madhadi.comData Integrity & GxP Quality
Browse all topics -> Articles Templates & Procedures Learning paths GlossaryScenariosToolsRegulatory ReferencesLearning PathsTopics About Start here
Protocol Plug-and-play starting point Cell & Gene Therapy

Protocol: Reference Standard Qualification and Bridging (Primary and Working Standard)

A plug-and-play protocol for qualifying a primary reference standard, establishing a working standard against it, and bridging any replacement: source and characterization, assigned potency, linkage acceptance criteria, and a worked bridging-study example, with a filled specimen.

Document type: Protocol

Read and copy the template below into your own quality system. It is a generic starting point for your own internal use, provided as is, with no warranty; see the Terms and License. Adopting it does not by itself create compliance.

This is a ready-to-use protocol for qualifying a reference standard and bridging every replacement, the control that makes every relative potency result meaningful. It covers a two-tier structure (primary and working standard), the linkage study that ties a working standard to the primary, and the bridging study run before any standard is switched. Replace every <<FILL: ...>> placeholder and route it through document control. A filled specimen follows. This is general guidance to adapt and verify, not legal or regulatory advice.

Approval page

FieldEntry
Document titleReference Standard Qualification and Bridging, <<FILL: product / assay>>
Document number<<FILL: PROT-ID, e.g. RS-QUAL-001>>
Version / effective date<<FILL>>
Product / stage<<FILL: product, phase or commercial>>
Linked potency method<<FILL: method ID, version>>
Supersedes<<FILL: prior version or "New">>
ApprovalNameSignatureDate
Author (Analytical / Bioassay)<<FILL>>
Reference Standard custodian<<FILL>>
Statistics<<FILL>>
Quality Assurance<<FILL>>

1. Objective

Qualify a primary reference standard, establish a working standard against it, and define the bridging study run before any future standard replacement, so that every relative potency result generated against these standards remains traceable to a documented, equivalence-tested chain rather than an unqualified material.

2. Scope

Covers the reference standard supporting <<FILL: potency method ID>>. It does not cover the potency assay’s own validation (governed by the assay validation protocol) beyond the assay’s role in the linkage and bridging studies described here.

3. Two-tier structure

ItemDetail
Primary reference standard<<FILL: description>>; changes rarely, held in restricted, limited-access storage
Working reference standard<<FILL: description>>; used for routine testing, periodically re-linked to the primary
RationaleThe primary is preserved by never being used for routine release testing; the working standard absorbs the day-to-day consumption and is the one bridged when it runs low

4. Primary reference standard qualification

StepRequirement
Source<<FILL: well-characterized lot, clinically relevant history, or bridge to an international/compendial standard where one exists>>
Characterization<<FILL: full analytical panel beyond routine release: identity, purity, higher-order structure, potency>>
Assigned potency<<FILL: defined as 100% against itself, or assigned via a bridging comparison to a prior/international standard>>
Stability program<<FILL: storage condition, retest/expiry interval, stability protocol reference>>
Qualification report<<FILL: report ID>>, documents source, characterization data, assigned value and its basis, storage conditions, and retest interval

5. Working standard establishment and linkage

StepRequirement
Working standard material<<FILL: preparation, representative of routine manufacture, sized for expected consumption>>
Linkage study designTest the candidate working standard against the primary across <<FILL: number, e.g. 6>> independent runs, spanning <<FILL: days / analysts>>
Assigned potencyMean relative potency observed against the primary across the linkage runs
Linkage acceptance criteria (pre-set)Mean relative potency within <<FILL: e.g. 80-125%>>; run-to-run variability (%GCV) not more than <<FILL: e.g. 15%>>
Working standard stability program<<FILL: storage condition, retest interval>>

Set the linkage acceptance criteria before running the study. A criterion chosen after seeing the data is not a criterion; it is a rationalization.

6. Two-tier bridging protocol (replacing a standard)

Bridge every replacement before switching. Never let a standard run out before the bridge is complete.

  1. Trigger. Start the bridging study ahead of depletion or expiry of the standard being replaced, per the trigger point in section 8.
  2. Side-by-side testing. Test the old and new standard across <<FILL: number>> independent runs, using the same design (days, analysts, plates) as the original linkage study in section 5.
  3. Apply the same pre-set acceptance criteria used for the original linkage (section 5), unless a documented, pre-approved deviation states otherwise.
  4. Assign the new standard’s potency from the bridging data, against the prior working standard, or against the primary if the primary itself is being replaced.
  5. Adjudicate. Meets criteria: qualify the new standard, set an effective date, archive the old standard’s data and remaining inventory per the retention schedule. Does not meet criteria: investigate before any switch; do not release product against an unbridged standard.
  6. Trending impact. Assess whether historical potency trend charts and control limits need a documented annotation or re-basis at the changeover, so the reference standard bridge itself is never mistaken for a process or product signal.

7. Acceptance criteria (overall)

  • The primary standard is characterized beyond routine release and has its own stability program.
  • The working standard is linked to the primary by a pre-specified, passed linkage study.
  • No standard is used for release testing before its qualification or linkage is approved.
  • Every replacement is bridged before the prior standard is exhausted, using the same pre-set criteria as the original linkage.
  • The trending impact of every bridge is assessed and documented.

8. Trigger points, deviation handling, summary, approvals

ItemRequirement
Bridging trigger point<<FILL: e.g. at 25% of working standard inventory remaining, or 6 months before expiry, whichever is earlier>>
Deviation handlingRecord any execution deviation from this protocol, assess impact on the linkage or bridging conclusion, resolve, and re-test if needed
Summary and approvalsSummarize results against acceptance criteria, state the qualified/bridged status, and obtain approvals

Filled specimen (bridging study)

RunNew candidate standard, relative potency vs. old standard
196%
2103%
399%
4105%
5101%
698%
Mean100.3%
%GCV3.2%
Pre-set acceptance criterionMean within 80% to 125%, %GCV not more than 15%
DecisionBoth criteria met: new standard qualified, assigned potency 100% (redefined against itself going forward), effective date set, old standard retired to the reference archive

Reading: six independent runs characterize both the average shift and the run-to-run noise of the bridge, not a single comparison that could be an outlier. The mean sits close to 100% and the variability is well inside the pre-set limit, so the bridge is clean and the new standard is adopted on its effective date without re-basing the specification. Had the mean landed outside the acceptance range, the switch would have triggered an investigation into whether the old standard had drifted, the new standard was mischaracterized, or both, before any release testing relied on the new material.

Common inspection findings this protocol prevents

  • A reference standard replaced with no documented bridging study, so relative potency results before and after the switch are not comparable on any evidence basis.
  • A working standard used for release testing before its linkage to the primary is complete or passing.
  • Linkage or bridging acceptance criteria chosen after seeing the comparison data.
  • A step change in the potency trend at a standard changeover investigated as a process deviation when it was, in fact, an unassessed reference-standard shift.

How to adapt

  1. Set your document number and link the potency method.
  2. Set the linkage and bridging acceptance criteria from your assay’s own precision data, not the example numbers.
  3. Set the bridging trigger point (inventory level or time before expiry) so bridging studies never run against the clock.
  4. Confirm the retention period for retired reference standard data and inventory against your records retention schedule.
Use madhadi.com as an app Full screen, works offline, one tap from your home screen.